The development of non-surgical techniques for the relief of malignant low bileduct obstruction has cast doubt on the best way of relieving jaundice, particularly in patients fit for surgery whose life expectancy is more than a few weeks.
We did a randomised prospective controlled trial comparing endoscopic stent insertion and surgical biliary bypass in patients with malignant low bileduct obstruction. In our department percutaneous cytodiagnosis was widely used during the 1970's and the first half of the 1980's, but due to the high proportion of false negative findings it is today only practised in those with unquestionably advanced disease to strengthen the basis for the discussion with the patient and his/her family on prognosis and palliation (4) . In patients with metastatic disease preoperative staging is often accurate especially if cytology is done but the problematic clinical situation arises in the patient with suspected local unresectability who is otherwise healthy and fit for a major operation. Then an exploratory laparotomy should always be done preferably by a surgeon who is prepared to go on with a pancreaticoduodenectomy when appropriate.
The authors found an equal procedural and therapeutic success rate after endoscopic and surgical bypass, respectively. The procedure related mortality was significantly lower after endoscopic than after surgical bypass. However, the 30-day mortality was similar in the two groups. Thus, the patients in the worst general condition succumb early after surgery but after endoscopic treatment they die anyhow within one month, thus questioning the advantages of endoscopy in this particular respect. Furthermore, the postoperative mortality rate was higher than reported in some recent studies on palliative bilioenteric anastomoses 5'6'7.
One tentative reason for this could be that several ofthe surgical bypasses were done in different referring hospitals outside the Middlesex, whereas the endoscopy was fully in the hands of the experts of this hospital. There were fewer major early complications after endoscopy than after surgery whereas late complications, such as recurrent jaundice and gastric outlet obstruction, were more frequent in the endoscopy group. Surprisingly the rate of cholangitis attacks after the two procedures, respectively, were not given. There was no difference in overall survival between the two treatments.
The study by Smith and associates is important as it is prospective, randomized and of sufficient statistical power. However, as pointed out above, the unexpectedly high early mortality rate after biliodigestive bypass does not do full justice to surgery, even if the statistics are correct. Thefindings ofthe study, though, lend support to the strategy which is currently practised at many centers such as ours. All patients with a suspicion ofextrahepatic biliary obstruction undergo ERCP. If a malignant typeof obstruction is found, stenting is done at the same session. Patients who turn out to suffer from definitely incurable disease will get no further treatment whereas those without signs ofmetastases or clearcut unresectability on imaging tests will have a laparotomy with the aim of resection. Staging laparoscopy is presently being evaluated but its clinical value and cost-effectiveness needs confirmation (8) .
Surgery There is fast development in both the surgical, especially the laparoscopic, and the endoscopic approachs to the palliative relief of malignant bile duct obstruction. The two techniques complement each other and the study by Smith and associates helps in defining their current roles.
